Skip to Content

Pamidronate Disodium Solution For Injection

Last Updated: May 24, 2018
Status: Resolved

Products Affected - Description
    • Pamidronate disodium injection, Mylan Institutional, 3 mg/mL, 10 mL vial, 1 count, NDC 67457-0430-10
    • Pamidronate disodium injection, Mylan Institutional, 9 mg/mL, 10 mL vial, 1 count, NDC 67457-0446-10
    • Pamidronate disodium injection, Pfizer, 3 mg/mL, 10 mL vial, 1 count, NDC 61703-0324-18
    • Pamidronate disodium injection, Pfizer, 6 mg/mL, 10 mL vial, 1 count, NDC 61703-0325-18
    • Pamidronate disodium injection, Pfizer, 9 mg/mL, 10 mL vial, 1 count, NDC 61703-0326-18
Reason for the Shortage
    • Mylan Institutional did not provide a reason for the shortage.
    • Pfizer has pamidronate on shortage due to manufacturing delays.
Available Products
    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Mylan Institutional has pamidronate 3 mg/mL and 9 mg/mL 10 mL vials on back order and the company estimates a release date of early-August 2018.
    • Pfizer has pamidronate 3 mg/mL 10 mL vials and 9 mg/mL 10 mL vials on back order and the company estimates a release date of June 2018. The 6 mg/mL 10 mL vials are available in limited supply.

Updated

Updated May 24, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 6, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide